BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Breast-Cancer Patients Under 40 May Keep Fertility With Drug, National Institute for Cancer Research Study Finds


7/20/2011 7:56:08 AM

Younger women with early-stage breast cancer who took a drug to suppress their ovaries were more likely to avert early menopause caused by chemotherapy, researchers found. The treatment, triptorelin, helped patients avoid the permanent loss of their fertility that can be prompted by chemotherapy’s toxic doses, according to research published today in the Journal of the American Medical Association. Two out of every five women under 40 who undergo chemotherapy for breast cancer lose the ability to conceive children, the researchers said. The use of triptorelin reduced the rate of early menopause by more than 17 percentage points, according to the results of a late-stage clinical trial called Promise-GIM6.

Read at Bloomberg
Read at News Release
Read at News Release

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES